Article
[OPRD1 gene polymorphism (rs4654327) as a potential predictor of the effectiveness of long-acting naltrexone in patients with alcohol addiction].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova - 1 Jan 2026
Miroshkin S S, Skryabin V Y, Shipitsyn V V, Masyakin A V
Abstract excerpt
OBJECTIVE: To evaluate the effect of the A>G (rs4654327) polymorphism of the OPRD1 gene on the clinical efficacy of long-acting naltrexone therapy in patients with alcohol addiction. MATERIAL AND METHODS: The study included 100 patients with alcohol addiction treated with long-acting naltrexone for 180 days. The duration of remission, the recurrence rate, the completion of the treatment course, the change of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
